Edit |   |
---|---|
Antigenic Specificity | CD51, Human (Abituzumab biosimilar) |
Clone | Abituzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Inhib, Agonist |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD51 Recombinant Antibody. Abituzumab is a humanized IgG2 monoclonal antibody (mAb) targeted at CD51 (an integrin) currently in development by Merck KGaA Darmstadt, Germany in an attempt to prevent bone lesion metastases in castration-resistant prostate cancer. |
Immunogen | n/a |
Other Names | Anti-CD51 Recombinant Antibody, Research Grade Abituzumab, Anti-Human CD51 Recombinant Antibody, DI-17E6, EMD 525797, Antibody Drug Analogues, Monoclonal Antibody, YR1330, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1105038-73-0 |
Catalog # | YR1330 |
Price | please inquire |
Order / More Info | CD51, Human (Abituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |